Competition Commission's probe into pharmaceutical companies: Hardin Ratshisusu

227 views · Published 13 June 2017 · 5:28 · Indexed 31 October 2026

Channel: SABC News · 2017 · News & Politics

Watch on YouTube

The Competition Commission has launched a probe into big name pharmaceutical companies that stand accused of ramping up prices for life-saving cancer drugs. It announced a series of investigations involving Roche, Aspen and Pfizer. Saying it was a matter of grave national importance. Concerns have been raised by civil society organisations such as Advocates for Breast Cancer and Section 27. 
The Commission says it has reason to believe that Roche and Pfizer may be engaged in excessive pricing. It says it suspects that Roche is engaging in the 'ever-greening' of a breast cancer treatment, meaning it changes the drugs slightly to get a new patent which stops cheaper, generic drugs from entering the market. It also has its sights on Aspen, which is listed on the JSE, has also been investigated for its pricing strategies abroad. Aspen has responded saying it has not increased pricing of its products outside the regulatory framework. 
It says it has clearly demonstrated its commitment to providing quality drugs affordable, and oncology products are no exception. 
Aspen shares were unchanged at the close of the JSE. 

For more news, visit: http://www.sabc.co.za/news

More from this channel